Navigation Links
Use of Transcriptor Reverse Transcriptase,,,in Microarray Analysis

Researchers studying tissue and cellular differences in gene expression have applied microarray analysis to questions ranging from cancer research to plant development studies. Although the method is well established, many of the steps in the process continue to be optimised to increase overall sensitivity and reliability. Here, we monitor gene expression in the obligate intracellular pathogen Toxoplasma gondii in order to compare reverse transcriptase target labelling performance on a custom T. gondii 12,000 cDNA microarray. A histogram of signal intensities shows that the Transcriptor Reverse Transcriptase produced a major shift in the signal distribution to higher signal intensity classes compared with the most commonly used RNase H- M-MuLV reverse transcriptase. This indicates the generation of a labelled target with an overall higher specific activity. The correlation of Cy5/Cy3 ratio data from four replicate microarrays demonstrate that target labelling with Transcriptor Reverse Transcriptase is highly reproducible and produces fewer outlier signals compared with the updated version of the RNase H- M-MuLV reverse transcriptase. The known enzymatic properties of Transcriptor Reverse Transcriptase suggest that it will produce a labelled target that closely reflects the experimental input RNA.

Introduction

Microarray analysis of gene expression is rapidly becoming a common tool for molecular biological investigations. The ability to simultaneously monitor tens of thousands of genes affords an unprecedented view of the transcriptional changes that underlie cellular processes. Microarrays are ideal for genetic investigations of intracellular pathogens such as Toxoplasma gondii because it is possible to simultaneously monitor gene expression in both host and pathogen [1]. However, the system must be optimised for pathogen gene expression since the T. gondii RNA can be more than an order of magnitude less concentrated compared with the host cell RNA. Over the past few years, technological advances have made the method much more reliable and robust.

Curiously, the standard protocols for generating the labelled cDNA target from the experimental RNA, arguably the most critical step in the procedure, remain virtually unchanged. The vast majority of investigators use either a direct incorporation of deoxynucleotides with covalently attached fluorophores or the incorporation of amino-allyl deoxynucleotides with subsequent fluorophore conjugation. In both methods, the efficiency of the target labelling reaction and quality of the labelled cDNA product depend almost entirely on the reverse transcription enzyme used.

We employ an amino-allyl labelling reaction to generate and compare microarray data from different commercially available reverse transcriptases.

Materials and Methods

Parasite and RNA preparation

Parasites (RH strain) were cultured according to a standard protocol. NIH 3T3 cells were used as host cells, and the parasites were harvested by centrifugation just prior to monolayer lysis. The cells were suspended in TRI reagent (Sigma). RNA was extracted according to the manufacturers protocol, except that the RNA was not ethanol precipitated following incubation with 2-propanol, but was added directly to an RNeasy Midi column (Qiagen). Binding of the sample was followed directly with the recommended wash and two extra washes. The RNA was eluted with a total of 450 l RNase-free water. This was followed by a standard ethanol precipitation. The RNA was vacuum dried and resuspended in RNase-free water to a final concentration of 1 g/l.

Target labelling reaction

Labelling was performed using a modified version of the published protocol from the DeRisi laboratory (www.microarrays.org). The modifications included an increase in the ratio of amino-allyl-dUTP:dTTP to 6:4. The neutralisation was performed with Tris-HCl. All reverse transcription reactions were performed at 42C using 15 g of total RNA previously extracted as described above. The total unit amount of Transcriptor Reverse Transcriptase was 20 units per reaction (10 units added, and 1 hour later another 10 units were added). The total unit amount of product Y was 400 units per reaction (400 units added and left for 2 hours according to the manufacturers recommended protocol). The labelled product was vacuum dried and finally resuspended in 34.5 l HGMP hybridisation buffer (40% formamide, 5x Denhardts solution, 5x SSC, 0.05 M Tris-HCl pH 7.4, 1.0 mM sodium pyrophosphate, 0.1% SDS), 0.4 g yeast tRNA, 0.96 g poly-dA and 2.7% SDS (www.hgmp.mrc.ac.uk/Research/Microarray/ index.jsp).

Hybridisation

The microarrays used in this study are from a single printing run, custom made with approximately 12,000 sequenced expressed-sequence tags (ESTs) from a nonnormalised library. The ESTs were PCR amplified and the products used for printing were analysed for content and quality on agarose gels. Every microarray was visually inspected and samples were prescanned for printing defects. The microarrays were preblocked (10% BSA, 3x SSC) for 1 hour at 55C. Slides were washed with Milli-Q water (Millipore), and dried by centrifugation. Fixation of cDNA products was achieved after boiling the product and submersing it in 95% ethanol. It was prehybridised (0.001% SDS, 10% BSA, 3x SSC) at 55C for 25 minutes, washed twice in Milli-Q water and washed in 100% ethanol. Hybridisation was carried out in a humid Arraylt hybridisation cassette using a lifter slip coverslip (Erie Scientific) overnight in a 42C water bath. Post hybridisation, the slides were washed for 4 minutes in progressively reduced SDS concentrations (solution 1: 0.5x SSC, 0.1% SDS; solution 2: 0.5 x SSC, 0.01% SDS; solution 3: 0.06 x SSC). Finally, the slides were dried by centrifugation.

Spot finding and scanning

The slides were scanned using an Axon 4000A Scanner according to the manufacturers instructions. The images were spot-found using GenePix 4.1 software with a fixed spot diameter of 150 mm. The median fluorescence value for the spot was used for final analysis without background correction or within chip normalisation.

Data analysis

Microsoft Excel was used to create the correlation curves and histogram data. The Cy5/Cy3 data were also exported from Microsoft Excel into GeneSpring 6.0 for final analysis of gene-specific effects.

Results and Discussion

Since a single microarray experiment consists of multiple steps, the evaluation of any particular step is assessed from the resulting data. Ideally, the labelled target should accurately reflect the input mRNA in both content and representation, have a high specific activity to maximise sensitivity and be very consistent between reactions using the same input mRNA. The first of these properties is inferred from prior enzymology. The second and third properties are experimentally evaluated using the scheme outlined in Figure 1. Briefly, a single RNA source is used throughout and each target labelling represents an independent reverse-transcriptase and dyecoupling reaction. Data from each microarray are derived from two independently labelled targets simultaneously hybridised to a single microarray.



Although the relative specific activities of a hybridised labelled target can be estimated by total mean fluorescence over an entire microarray signal set, the distribution of signal intensities on a per-spot (probe) basis is more informative. Figure 2 illustrates a histogram of three representative sets of 9,737 raw (nonnormalised) fluorescent signals from the Cy5 channel. Compared with Transcriptor Reverse Transcriptase there is a much greater abundance of signals in the 0 5,000 class and relative paucity of signals in the higher fluorescence classes for product X. This signal distribution indicates that Transcriptor Reverse Transcriptase labels cDNA more efficiently than product X. In contrast, Transcriptor Reverse Transcriptase and product Y show similar signal distributions where more than half of the signals were in classes greater than 5,000. Members of the highest signal class are signals at saturation, some of which are T. gondii gene transcripts known to be in very high abundance. The high number of signals in this class for Transcriptor Reverse Transcriptase indicates a relatively strong labelling reaction compared with the low signal numbers for product X. Since the optimal laser power and PMT levels were similar for all three microarray scans, image acquisition can not account for the difference in results.



Consistency of target labelling is critical for microarray analysis of gene expression to detect real transcriptional differences between experimental treatments. Since the same input RNA was used in all experiments, it was possible to test an enzymes ability to generate reproducible results; microarrays using Transcriptor Reverse Transcriptase and product Y were replicated four times each. Ratio (Cy5/Cy3) data from each of the four replicates plotted against the mean show similar results, where the Transcriptor Reverse Transcriptase replicates show generally better correlation to the mean than product Y (Figure 3). This appears to be due to fewer outlier spots that depart substantially from the trend lines in the four Transcriptor Reverse Transcriptase replicates.



The replicate data were processed in GeneSpring to detect particular spots that are consistently biased towards greater signal in either Transcriptor Reverse Transcriptase or product Y. Inspection of a few cDNA probes showed that the greatest signal bias towards Transcriptor Reverse Transcriptase appear to be in those probes that are substantially truncated, and those with a greater signal bias towards product Y are truncated much closer to the 5′ end. Although this anecdotal observation could be interpreted in several ways, it is at least consistent with the notion that the high processivity of Transcriptor Reverse Transcriptase may produce a better labelled target and more robust data in cases where the spot/probe cDNA is substantially truncated.

Conclusion

The histogram of signal intensity distributions show that Transcriptor Reverse Transcriptase can be used for high efficient target labelling. Since many investigators eliminate data with signal intensities below a particular threshold (e.g.,1,0002,000), an increased specific activity of the labelled target may be critical for analysing genes with low expression.

In general, the data above suggest that Transcriptor Reverse Transcriptase produces a labelled target with results similar to those of the updated RNase HM- MuLV reverse transcriptase. But Transcriptor Reverse Transcriptase appears to produce a more consistent labelled target, as the four replicates generally correlate better, with noticeably fewer outlier spots. The known enzymatic properties of Transcriptor Reverse Transcriptase (high processivity and RNase H activity) should produce a labelled target that closely reflects the experimental input mRNA. This will be critical for using the latest generation of oligonucleotide microarrays, which include probes designed to the 3′ end of a transcript to facilitate the analysis of mRNA splice variants, multiple poly-A+ addition sites, etc.




'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Transcriptor Reverse Transcriptase
2. Increase the Power and Sensitivity for Your cDNA Synthesis with the New Transcriptor Reverse Transcriptase
3. Properties of Reverse Transcriptases
4. Reverse transcriptases suitable for one-step RT-PCRb
5. Reverse transcriptases suitable for two-step RT-PCRd
6. C. therm. Polymerase for Reverse Transcription in Two-Step RT-PCR
7. Recombinant HIV Reverse Transcriptase
8. Novel Bonding Chemistry Imparts Enhanced Polar Selectivity to TSK-GEL ODS-100V Reversed Phase Columns
9. New Microarray Labeling Kit for Preparing cDNA Probes
10. Stratagenes Human cDNA Microarrays: Perform Gene Expression Profiling and Discover New Genes
11. An Optimal DNA Microarray Substrate for the Identification of Fetal and Somatic Liver Stem Cells of the Rat
Post Your Comments:
(Date:8/21/2014)... Wednesday of last week RENU 28, the world's first and ... for purchase in Australia and New Zealand, and the response ... is, if you think about the definition of aging, it's ... within your body. If you think about the definition of ... What RENU 28 does is it works with these tiny ...
(Date:8/20/2014)... Fla. , Aug. 20, 2014 ... will host a conference call to provide an ... 2014Time:4:30 p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. ... 9126599 Live web cast: www.neurotropebioscience.com , under "Investor ... hours after completion through September 2, 2014 at ...
(Date:8/20/2014)... August 20, 2014 Not long ago, ... studies should be performed late in the development cycle ... But current regulatory trends suggest that, like many things ... rise. In recent years, multiple drug sponsors have been ... address specific questions during phase I/II. It’s not only ...
(Date:8/19/2014)... 20, 2014 One of the ... is an inadequate vascular supply. Nutrient and gas ... tissues is critical for successful regeneration and integration ... mitigate deficiencies in vascularization and promote angiogenesis in ... optimizing scaffold design and architecture, and enhancing scaffolds ...
Breaking Biology Technology:RENU 28 Skin Care Now Available in Australia and New Zealand 2Neurotrope To Host Conference Call 2Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2
... N.J., Oct. 4 In conjunction with,its third quarter 2007 ... 24), Covance Inc. (NYSE: CVD ) is pleased to ... will be broadcast,live over the Internet on Thursday, October 25 ... Quarter 2007 Earnings Webcast and Slide Presentation When: ...
... Inc.,(NYSE: SMA ), an independent provider of ... medical markets, announced today that the Audit,Committee of ... review of,apparent irregularities with respect to the Company,s ... unit. The review follows a,report by management earlier ...
... today announced that Solomon Steiner, Chairman and CEO of Biodel,will ... San,Francisco, CA on October 11th at 11:00 AM PT. ... webcast of the,presentation in the investor relations section of Biodel,s ... be available for,14 days. About Biodel Inc. Biodel ...
Cached Biology Technology:Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement 2Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement 3Biodel Inc. to Present at BIO InvestorForum 2007 Conference on October 11, 2007 2
(Date:8/21/2014)... smog-producing toxins in past decade, GTA still violates ... that while the Greater Toronto Area (GTA) has ... to smog, the city continues to violate the ... can cause or aggravate health problems such as ... a set of complex photochemical reactions involving volatile ...
(Date:8/21/2014)... 2014 Nxt-ID, Inc. (OTCQB: NXTD), a biometric ... announced today that its shares of common stock and ... in its proposed underwritten public offering of common stock ... Nasdaq Capital Market, subject to closing of its proposed ... and will trade under the symbol "NXTD" and "NXTDW," ...
(Date:8/21/2014)... are the ultimate source of all organic matter that ... algae, too, to suck up climate-warming carbon dioxide from ... the ocean. Now, by using a combination of satellite ... viruses infecting those algae are driving the life-and-death dynamics ... essentially the same, and this has important implications for ...
Breaking Biology News(10 mins):Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3Viruses take down massive algal blooms, with big implications for climate 2
... Boston, MA - Tiny particles only billionths of a meter ... human haircould offer big hope in a small package to the ... everything from jewelry to coins and cell phones, say scientists at ... issue of Nature Nanotechnology, the team will report a ...
... the largest study of its kind, researchers from a consortium ... linked to late-onset Alzheimer,s disease. Each of these genes adds ... the disease, and together they offer a portal into the ... to determine who is at risk of developing the disease, ...
... Medicine researchers are part of a consortium that has identified ... a person developing Alzheimer,s disease later in life. The ... The consortium also contributed to the identification of a ... United States and Europe. "Mount Sinai has unique resources ...
Cached Biology News:Nanoparticles offer hope for common skin allergy 2Nanoparticles offer hope for common skin allergy 3Alzheimer’s disease consortium identifies four new genes for Alzheimer’s disease risk 2Alzheimer’s disease consortium identifies four new genes for Alzheimer’s disease risk 34 new genes identified for Alzheimer's disease risk 2
Bovine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11:...
...
... deuterium atoms at the 9, 10, 12, and ... an internal standard for the quantification of 13(S)-HODE ... by incubation of linoleic acid with plant and ... the adhesion of tumor cells to the endothelium ...
...
Biology Products: